Citigroup

Citigroup’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Citigroup’s Portfolio GEVA Stock Details GEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell
2015 Q1	$2.41M	Buy
2014 Q4	$1.25M	Buy
2014 Q3	$177K	Buy
2014 Q2	$230K	Sell
2014 Q1	$577K	Sell
2013 Q4	$529K	Buy
2013 Q3	$341K	Buy
2013 Q2	$24K	Buy